✦ LIBER ✦

Biomarkers and surrogate endpoints

✍ Scribed by J. K. Aronson

Book ID: 108641385
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 72 KB
Volume: 59
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2005.02435.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulatory surrogate endpoint biomarkers

✍ Suzanne A. Fuqua 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Comparing Biomarkers as Principal Surrog

Comparing Biomarkers as Principal Surrogate Endpoints

✍ Ying Huang; Peter B. Gilbert 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

Intraepithelial neoplasia, surrogate end

Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention

✍ Dr. Charles W. Boone; Gary J. Kelloff 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 930 KB

Neoplasia is a progression of molecular, cellular, and tissue changes starting with a critical cell mutation and advancing by clonal evolution, involving further multiple mutations and expanding mutated clones. This process is characterized by five general stages: latency, focal growth of normal-app

Cervical cancer chemoprevention, vaccine

Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkers

✍ Michele Follen; Frank L. Meyskens Jr.; Ronald D. Alvarez; Joan L. Walker; Maria 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 883 KB

At the Second International Conference on Cervical Cancer, held April 11-14, 2002, experts in cervical cancer prevention, detection, and treatment reviewed the need for more research in chemoprevention, including prophylactic and therapeutic vaccines, immunomodulators, peptides, and surrogate endpoi

Imaging biomarkers as surrogate endpoint

Imaging biomarkers as surrogate endpoints for drug development

✍ Wolf S. Richter 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 100 KB

Surrogate endpoints

✍ Ellenberg, SS 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 644 KB